Increased serum levels of the phosphaturic hormone FGF23 have been associated with progression of CKD [37], vascular calcification [38, 39], left ventricular hypertrophy [40], and cardiovascular mortality [41]; however, the impact of FGF23 on vascular calcification remains controversial [42]. Here, FGF23 is linked to chronic kidney disease.